Pharmaceutical

Blockchain Revolutionizes Pharmaceutical Industry with Transparency
Clinical & Pharma Blockchain Revolutionizes Pharmaceutical Industry with Transparency

Blockchain technology is making waves across various industries, and the pharmaceutical sector is no exception. With its decentralized and secure digital ledger systems, blockchain is poised to address some of the industry's most persistent challenges, including counterfeit drugs, supply chain

Can Torrent Pharmaceuticals Sustain Its Robust Market Performance?
Clinical & Pharma Can Torrent Pharmaceuticals Sustain Its Robust Market Performance?

The recent surge in Torrent Pharmaceuticals' share price has captured the attention of investors and market enthusiasts, reflecting a substantial bullish trend of 2.63% as of December 19, 2024. Trading at ₹3,467.00, the stock manifests a notable performance in the pharmaceutical sector, raising

How Will the 2024 Pharma Trends Shape Global Healthcare?
Clinical & Pharma How Will the 2024 Pharma Trends Shape Global Healthcare?

The pharmaceutical industry is undergoing significant transformations in 2024, driven largely by advancements in drug development, manufacturing challenges, and evolving legislative landscapes. Innovations in medication are creating a seismic shift, rippling through healthcare systems worldwide.

How Will Afreximbank and Med Aditus Transform Kenya’s Pharma Industry?
Clinical & Pharma How Will Afreximbank and Med Aditus Transform Kenya’s Pharma Industry?

The recent partnership between African Export-Import Bank (Afreximbank) and Med Aditus Pharmaceutical Kenya Limited (Med Aditus) marks a significant milestone in the pharmaceutical industry in Kenya. This collaboration aims to boost local pharmaceutical production, ensuring access to affordable and

Is ANI Pharmaceuticals a Good Investment with a 'Moderate Buy' Rating?
Clinical & Pharma Is ANI Pharmaceuticals a Good Investment with a 'Moderate Buy' Rating?

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) has garnered notable attention from various research firms recently, leading to an overall consensus rating of "Moderate Buy." The evaluation by these firms reflects a mixture of ratings, with one analyst assigning a hold rating and five others issuing a buy

Uncertain Future of Health Care Policy Under Trump Administration
Clinical & Pharma Uncertain Future of Health Care Policy Under Trump Administration

As the Trump administration took the reins of power, the health care industry faced a period of unprecedented uncertainty, driven by the potential impacts of new policies on various sectors, including hospitals and pharmaceuticals. With the Republicans gaining control of the White House and

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later